Akebia Ther
Price & Volume
Stats
See more52W Range | $1.14-$4.07 |
Market Cap | $350.2M |
Shares Short | 31M |
Financials
See moreRevenue (12 Mos) | $236.1M |
Revenue Growth (YoY) | 23.9% |
Gross Profit (12 Mos) | $193.3M |
Diluted EPS | -$0.08 |
News
See moreYahoo Finance • 4 days ago
Here are the major earnings before the open Thursday
Yahoo Finance • 11 days ago
Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights
Yahoo Finance • 3 months ago
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 3 months ago
Akebia Announces Establishment of Rare Kidney Disease Pipeline
About
CEO | Mr. John P. Butler MBA |
CFO | Mr. Erik John Ostrowski M.B.A. |
Address | 245 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 181 |
